Imatinib solubility dmso
WitrynaDescription. Imatinib (STI571, CGP057148B, Gleevec) Mesylate is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit … WitrynaErlotinib hydrochloride (774 hydrochloride ); >= 98% HPLC; Erlotinib hydrochloride has been used to activate mitochondrial fragmentation in a human PANC-1 pancreatic cancer cell line; Erlotinib hydrochloride is an antineoplastic drug; EGFR kinase inhibitor; Antineoplastic; Erlotinib hydrochloride i
Imatinib solubility dmso
Did you know?
WitrynaDimethyl sulfoxide (DMSO) is an organosulfur compound with the formula (CH 3) 2 S O.This colorless liquid is the sulfoxide most widely used commercially. It is an important polar aprotic solvent that … WitrynaImatinib. Molecular Formula C 29 H 31 N 7 O; Average mass 493.603 Da; Monoisotopic mass 493.259003 Da; ChemSpider ID 5101; ... DMSO 3 mg/mL; ... (Modified Grain …
WitrynaIt is an effective solvent for a wide array of organic materials, including many polymers. DMSO also dissolves many inorganic salts, particularly transition metals nitrates, … WitrynaImatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively). ...
WitrynaSolubility: 100 mg/mL (169.57 mM); Clear solution; Need ultrasonic. 2. ... (50 mg/kg) is injected intraperitoneally in the Imatinib group (n=7), and 0.5 mL of 20% DMSO … Witryna3 mar 2024 · See product citations (59) Alternate Names: Imatinib mesylate is also known as Imatinib methanesulfonate salt. Application: Imatinib mesylate is a c-Abl, PDGFR, and c-kit inhibitor that halts chronic myelogenous leukemia related growth. CAS Number: 220127-57-1. Purity: ≥99%. Molecular Weight: 589.71. Molecular Formula: C …
Witryna14 paź 2024 · Effect of solubility and permeability on PK metrics based on PBPK model simulations. AUC and C max ratios (hypothetical BCS class I-like solubility to best-fit solubility) from PBPK simulations are summarized in Table 2. Crizotinib, dabrafenib, gefitinib, imatinib, M1, and trametinib are insensitive to an increase in the input …
WitrynaIt is an effective solvent for a wide array of organic materials, including many polymers. DMSO also dissolves many inorganic salts, particularly transition metals nitrates, cyanides and dichromates. DMSO is miscible with water and most organic liquids. The contents of this page summarize solubility characteristics for DMSO. chums bereavement supportWitrynaImatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV. ... 10% DMSO 90% corn oil. Solubility: ≥ 1.25 mg/mL (2.53 mM); Clear solution * All of the ... detail brothers njWitrynaDescription. Imatinib (STI571,Gleevec, Glivec, CGP057148B) is a multi-target inhibitor of tyrosine kinase with inhibition for v-Abl, c-Kit and PDGFR, IC50 values are 0.6 μM, … detail by ship date 意味WitrynaImatinib Mesylate (STI571, CGP-57148B) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl , c-Kit and PDGFR with IC50 of 0.6 … detail brothersWitrynaImatinib is a benzamide obtained by formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary aromatic amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)pyrimidin-2 … chums bonding fleece jacketWitrynaImatinib, Methanesulfonate Salt, >99%, CAS#220127-57-1, This research compound is the methanesulfonate salt form of imatinib. Please see the free base form of impatinib, Cat No. I-5577, Imatinib, Free Base , for further technical information. ... Solubility: Soluble in DMSO at 100 mg/mL; very poorly soluble in ethanol; soluble in water at … detail brush paintingWitryna2 weeks 4°C in DMSO 6 months-80°C in DMSO Solubility (25°C) DMSO 3 mg/mL Water <1 mg/mL Ethanol <1 mg/mL Storage Description Imatinib is a multi-target inhibitor of … chums bed linen